Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 917
interventional 715
Observational 181
Registry 21

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 286
Biological 243
Drug|placebo 81
Other 21
Behavioral 16
Biological|placebo 13
Biological|Drug 12
Device 7
Procedure 7
Drug|Other 5
Biological|Procedure 4
Device|Drug 3
Behavioral|Biological 2
Biological|Drug|placebo 2
Diagnostic Test 2
Genetic 2
Behavioral|Other 1
Behavioral|placebo 1
Biological|Drug|Other 1
Biological|Other 1
Biological|Other|placebo 1
Device|Other 1
Dietary Supplement 1
Dietary Supplement|Drug|Procedure 1
Drug|Genetic 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
China 111
United States 72
NA 61
Korea, Republic of 50
Taiwan 22
Thailand 20
Belgium 19
Germany 17
India 14
Canada 13
France 13
Philippines 13
Hong Kong 12
Italy 8
Netherlands 8
Japan 7
Russian Federation 7
Spain 7
United Kingdom 7
New Zealand 6
Australia 5
Austria 5
Singapore 5
Belgium|Czech Republic|Hungary 4
Indonesia 4
United States|Canada 4
Vietnam 4
Bangladesh 3
Canada|France|Germany 3
Colombia|Costa Rica 3
Poland 3
South Africa 3
Turkey 3
United States|New Zealand 3
United States|Puerto Rico 3
Australia|Canada|Czechia|Finland|Italy|Spain 2
Australia|Hong Kong|Korea, Republic of|New Zealand|Thailand 2
Australia|New Zealand 2
Belgium|Czechia 2
Belgium|Germany 2
Brazil 2
Bulgaria 2
China|Hong Kong 2
China|Korea, Republic of 2
Congo, The Democratic Republic of the 2
Czech Republic|Malaysia|Spain 2
Dominican Republic|Finland 2
Finland 2
Hong Kong|Korea, Republic of 2
Mexico 2
Moldova, Republic of 2
United States|Australia|Canada|Korea, Republic of|New Zealand 2
United States|Canada|Hong Kong|Italy|Korea, Republic of|New Zealand|Taiwan|United Kingdom 2
United States|Canada|Hong Kong|New Zealand|United Kingdom 2
United States|New Zealand|Singapore|Taiwan 2
Afghanistan 1
Argentina 1
Argentina|Brazil|Germany|Thailand 1
Argentina|Nicaragua 1
Australia|Belgium 1
Australia|Belgium|Spain 1
Australia|Belgium|Ukraine 1
Australia|Bulgaria|China|Hong Kong|Korea, Republic of|New Zealand|Singapore|Taiwan|Thailand 1
Australia|Czech Republic|Germany|Italy|Netherlands|Switzerland|United Kingdom 1
Australia|Hong Kong|Korea, Republic of|New Zealand|Singapore|Taiwan|Thailand 1
Australia|Hong Kong|Korea, Republic of|Taiwan|United Kingdom 1
Australia|Hong Kong|New Zealand 1
Australia|Netherlands|Poland|Thailand 1
Australia|Thailand 1
Austria|Belgium|Denmark|Iceland 1
Austria|Bulgaria|Germany|Greece|Italy|Russian Federation|Spain|Turkey 1
Austria|Germany 1
Belgium|Bulgaria|France|Georgia|Germany|Malaysia|Moldova, Republic of|Romania|Spain|Taiwan 1
Belgium|Canada 1
Belgium|Canada|Sweden 1
Belgium|Czech Republic 1
Belgium|Czechia|Germany 1
Belgium|Denmark 1
Belgium|France|Germany|Italy|Poland|Spain|United Kingdom 1
Belgium|Germany|Philippines|United Kingdom 1
Belgium|Germany|Poland|United Kingdom 1
Belgium|Germany|Switzerland 1
Belgium|Germany|United Kingdom 1
Belgium|Netherlands 1
Bulgaria|China|Hong Kong|Korea, Republic of|New Zealand|Poland|Taiwan|United Kingdom 1
Bulgaria|Former Yugoslavia 1
Bulgaria|Hong Kong|Italy|Netherlands|New Zealand|Taiwan|Thailand|United Kingdom 1
Burkina Faso|Ghana 1
Côte D’Ivoire 1
Cambodia 1
Cameroon 1
Canada|China|France|Hong Kong|Korea, Republic of|New Zealand|Spain|Taiwan|Thailand|United Kingdom 1
Canada|Germany 1
Canada|Hong Kong|Korea, Republic of|Taiwan 1
Canada|Korea, Republic of|Taiwan 1
Canada|Moldova, Republic of|Ukraine 1
Canada|Netherlands 1
Canada|United Kingdom 1
Canada|United States|Australia|France|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Singapore|Taiwan 1
Chile 1
China|France|Korea, Republic of|Singapore|Taiwan|Thailand|United States|Australia|Canada 1
China|Hong Kong|Japan|Korea, Republic of|Philippines|Singapore 1
China|Netherlands 1
China|Netherlands|Poland|Romania|Turkey 1
China|United Kingdom 1
China|United States|Canada|France 1
China|United States|Korea, Republic of|Singapore|Taiwan 1
Czech Republic 1
Czechia|United States|Belgium|Brazil|Canada|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Malaysia|Poland|Russian Federation|Spain|Thailand|Turkey|United Kingdom 1
Denmark|Ethiopia|Norway|Sweden 1
Estonia|Latvia|Lithuania 1
Finland|Italy|Sweden 1
France|Germany|Italy|Netherlands|Poland|Romania|Spain 1
France|Italy|Spain|United Kingdom 1
France|Spain 1
France|United States|Australia|Bulgaria|Canada|Czech Republic|Germany|Greece|Italy|Netherlands|New Zealand|Poland|Spain|Turkey|United Kingdom 1
Germany|Hong Kong|Korea, Republic of|New Zealand|Singapore|United Kingdom 1
Germany|Italy 1
Germany|Poland|Spain 1
Germany|Russian Federation 1
Germany|United States|Australia|Canada|France|Hong Kong|New Zealand|Poland|Singapore|Taiwan|United Kingdom 1
Hong Kong|Korea, Republic of|Malaysia|New Zealand|Singapore|Taiwan 1
Hong Kong|Korea, Republic of|Singapore|Taiwan|Vietnam 1
Hong Kong|New Zealand|Singapore 1
Hong Kong|Singapore|Taiwan|Thailand 1
Iran, Islamic Republic of 1
Israel 1
Italy|United States|Australia|Belgium|Bulgaria|China|Germany|Israel|Poland|Russian Federation|Ukraine|United Kingdom 1
Kenya 1
Korea, Republic of|Moldova, Republic of|New Zealand|Thailand|Ukraine 1
Korea, Republic of|Taiwan 1
Korea, Republic of|United Kingdom 1
Lao People’s Democratic Republic|Thailand 1
Mexico|Peru 1
Morocco 1
Nigeria 1
Norway|Sweden 1
Peru 1
Philippines|Thailand 1
Slovakia 1
Sweden 1
Switzerland 1
Thailand|Australia|Brazil|China|Hong Kong|Korea, Republic of|New Zealand|Russian Federation|Singapore|Taiwan 1
Turkey|United States|Austria|Bulgaria|Canada|Czech Republic|Germany|Greece|Hungary|New Zealand|Poland|Romania|Serbia|Spain 1
Uganda 1
United States|Argentina|Australia|Brazil|Canada|France|India|Italy|Mexico|Poland|Russian Federation|South Africa|Turkey 1
United States|Argentina|Australia|Brazil|France|Italy|Korea, Republic of|Spain|Taiwan 1
United States|Argentina|Belgium|Brazil|Canada|Korea, Republic of|Taiwan|United Kingdom 1
United States|Argentina|Belgium|Canada|Germany|Greece|India|Israel|Korea, Republic of|Poland|Romania|Russian Federation|Taiwan|United Kingdom 1
United States|Australia|Belgium|Germany|Italy|Malaysia|Romania|Russian Federation|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Australia|Brazil|Canada|China|France|Germany|Israel|Korea, Republic of|New Zealand|Poland|Puerto Rico|Singapore|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Australia|Brazil|Canada|Greece|Hong Kong|India|Indonesia|Italy|Korea, Republic of|Malaysia|Philippines|Poland|Russian Federation|Singapore|Taiwan|Thailand|Turkey 1
United States|Australia|Brazil|China|France|Germany|Hong Kong|Korea, Republic of|New Zealand|Russian Federation|Singapore|Taiwan|Thailand 1
United States|Australia|Bulgaria|Canada|Czech Republic|France|Germany|Greece|Italy|Netherlands|New Zealand|Poland|Spain|Turkey|United Kingdom 1
United States|Australia|Bulgaria|Canada|France|Hong Kong|India|Italy|Japan|Korea, Republic of|New Zealand|Poland|Romania|Russian Federation|Singapore|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Canada|China|Czech Republic|France|Germany|Hong Kong|India|Israel|Italy|Korea, Republic of|New Zealand|Poland|Puerto Rico|Singapore|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Australia|Canada|China|France|Germany|India|Israel|Korea, Republic of|Latvia|Malaysia|New Zealand|Poland|Russian Federation|Singapore|Spain|Taiwan|Thailand|Turkey|United Kingdom|Vietnam 1
United States|Australia|Canada|China|France|Israel|New Zealand|Singapore|Taiwan|Thailand|United Kingdom 1
United States|Australia|Canada|France|Germany|Greece|Hong Kong|India|Italy|Korea, Republic of|Netherlands|Poland|Portugal|Romania|Singapore|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Canada|France|Hong Kong|India|Italy|Japan|Korea, Republic of|New Zealand|Poland|Romania|Russian Federation|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Canada|New Zealand 1
United States|Australia|Canada|New Zealand|United Kingdom 1
United States|Australia|China|Hong Kong|Korea, Republic of|New Zealand|United Kingdom 1
United States|Australia|Hong Kong|New Zealand|Philippines|Singapore|Taiwan|Thailand 1
United States|Belgium|Canada|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Malaysia|Poland|Russian Federation|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Belgium|Canada|Finland 1
United States|Belgium|Canada|Germany|United Kingdom 1
United States|Belgium|Canada|Hong Kong|India|Korea, Republic of|New Zealand|Romania|Russian Federation|Taiwan 1
United States|Brazil|Canada|France|Greece|Hong Kong|India|Indonesia|Philippines|Poland|Russian Federation|Singapore|South Africa|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Brazil|Mexico|Puerto Rico|South Africa 1
United States|Brazil|South Africa 1
United States|Bulgaria|France|Poland|Romania|Spain|Turkey 1
United States|Canada|France|Germany|Greece|Italy|Poland|Singapore|Spain|Taiwan|Turkey 1
United States|Canada|Hong Kong|Indonesia|Philippines|Singapore|Taiwan|Thailand 1
United States|Canada|Hong Kong|Italy|Korea, Republic of|Spain|Taiwan|United Kingdom 1
United States|Canada|Italy|Korea, Republic of|Netherlands|New Zealand 1
United States|Canada|Italy|Korea, Republic of|New Zealand|Romania 1
United States|Canada|Japan 1
United States|Canada|New Zealand 1
United States|China|Dominican Republic|France|Greece|Hong Kong|Japan|Korea, Republic of|Malaysia|Puerto Rico|Singapore|Spain|Taiwan|Thailand|Turkey 1
United States|Czechia|France|Germany|Hungary|Poland|Puerto Rico|Spain|United Kingdom 1
United States|France|Germany|Spain 1
United States|Germany|New Zealand 1
United States|India 1
United States|India|Korea, Republic of|Romania|Taiwan 1
United States|Japan|Korea, Republic of|Taiwan 1
United States|Korea, Republic of|Spain|Thailand|Turkey|United Kingdom 1
Zambia 1

Sites per Study

Site_count Study_Count
1 360
2 51
3 35
4 29
5 10
6 9
7 17
8 10
9 15
10 11
11 13
12 13
13 3
14 9
15 8
16 6
17 4
18 5
19 5
20 7
21 8
22 5
23 4
24 9
25 6
27 3
28 5
29 2
30 2
31 2
32 4
33 1
34 2
35 2
36 1
37 1
38 3
39 5
40 2
42 2
43 2
44 1
45 1
48 2
50 1
51 1
53 1
54 1
55 1
61 1
63 1
67 1
68 1
71 1
74 1
76 1
80 1
87 1
89 1
105 1
112 1
123 1
159 1
171 1

Phase

Phase Study_Count
Phase 4 190
Phase 3 189
Phase 2 125
N/A 93
Phase 1 81
Phase 1/Phase 2 23
Phase 2/Phase 3 13
Early Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 135
2 283
3 100
4 57
5 15
6 20
7 3
8 8
9 3
10 2
11 1
12 2
18 1
NA 85

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 52 6.0000 6.00000 8.00000 5.0000 30.0000 6.0000 5.0000
1st Qu. 52 110.0000 28.00000 30.00000 48.0000 81.5000 131.0000 72.0000
Median 52 200.0000 44.00000 39.00000 103.0000 120.0000 263.0000 154.5000
Mean 52 656.4301 54.80247 56.04348 191.7742 231.6667 501.4475 879.2128
3rd Qu. 52 451.0000 75.00000 72.50000 200.0000 204.7500 585.0000 303.7500
Max. 52 11900.0000 240.00000 200.00000 2464.0000 1091.0000 8374.0000 80000.0000

Trial Group Type

group_type Group_Count
Experimental 1029
Active Comparator 390
Placebo Comparator 95
NA 85
Other 49
No Intervention 43
Sham Comparator 3

Intervention Model

intervention_model Study_Count
Parallel Assignment 496
Single Group Assignment 166
Sequential Assignment 19
NA 16
Crossover Assignment 10
Factorial Assignment 8

Primary Purpose

primary_purpose Study_Count
Treatment 374
Prevention 275
Basic Science 14
Other 14
NA 12
Screening 9
Diagnostic 8
Health Services Research 5
Supportive Care 3
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
China 45
United States 24
NA 16
France 12
Korea, Republic of 10
Taiwan 10
Hong Kong 7
Germany 5
United States|Canada 5
Spain 4
Netherlands 3
Zambia 3
Australia 2
Belgium 2
Canada 2
India 2
Italy 2
Senegal 2
United Kingdom 2
Australia|France|Hong Kong|Italy|Korea, Republic of|New Zealand|Russian Federation|Singapore|Taiwan|Thailand 1
Austria|Bahrain|Bangladesh|Bosnia and Herzegovina|Bulgaria|China|Egypt|France|Germany|Hong Kong|India|Indonesia|Ireland|Jordan|Korea, Republic of|Lebanon|Macedonia, The Former Yugoslav Republic of|Morocco|New Zealand|Pakistan|Poland|Portugal|Romania|Saudi Arabia|Thailand|United Arab Emirates|United Kingdom 1
Austria|Bulgaria|China|France|Germany|Greece|Italy|Korea, Republic of|New Zealand|Poland|Portugal|Romania|Taiwan|Thailand|United Kingdom 1
Austria|Germany 1
Brazil 1
Bulgaria 1
China|Korea, Republic of|Malaysia|Singapore 1
China|United States|Argentina|Brazil|Canada|Colombia|Czechia|France|Germany|Greece|India|Italy|Korea, Republic of|Mexico|Philippines|Poland|Portugal|Romania|Russian Federation|Singapore|Spain|Taiwan|Thailand|Turkey 1
Egypt 1
Ethiopia 1
France|Italy 1
Gambia|Senegal 1
Greece 1
India|United States|Argentina|Brazil|China|France|Greece|Italy|Peru|Philippines|Poland|Romania|Russian Federation|Singapore|Spain|Taiwan|Thailand|United Kingdom 1
Japan 1
Mexico 1
Moldova, Republic of 1
Myanmar 1
Serbia 1
South Africa 1
Thailand 1
Uganda 1
United States|Australia|Bulgaria|Canada|Germany|Hungary|Italy|New Zealand|Romania|Turkey 1

Sites per Study

Site_count Study_Count
1 128
2 7
3 2
4 6
5 3
6 3
7 3
8 3
9 1
11 4
12 1
15 1
16 1
17 1
19 1
21 1
22 1
25 1
26 1
27 2
28 1
30 1
50 1
84 1
86 1
88 1
90 1
249 1
290 1
402 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 107.250
Median 400.000
Mean 3391.938
3rd Qu 1000.750
Max 161429.000

Observation Model

observational_model Study_Count
Cohort 115
Case-Only 21
NA 16
Other 11
Case-Control 6
Case Control 6
Defined Population, Natural History 2
Ecologic or Community 2
Family-Based 2

Time Perspective

time_perspective Study_Count
Prospective 113
Retrospective 37
Cross-Sectional 16
Other 8
NA 5
Longitudinal, Prospective 2

Registries

Studies by Country

Country Study_Count
China 7
Korea, Republic of 3
NA 2
Spain 2
United States 2
Cameroon 1
Portugal|Argentina|Austria|Belarus|Belgium|Bosnia and Herzegovina|Croatia|Czechia|Denmark|Estonia|Finland|France|Georgia|Germany|Greece|Hungary|Iceland|Ireland|Israel|Italy|Latvia|Lithuania|Luxembourg|Netherlands|Norway|Poland|Romania|Russian Federation|Serbia|Slovakia|Slovenia|Spain|Sweden|Switzerland|Ukraine|United Kingdom 1
Taiwan 1
United Kingdom 1
United States|Canada 1

Sites per Study

Site_count Study_Count
1 17
27 1
30 1
45 1
110 1

Enrollment Metrics

Measure Registries
Min 16.00
1st Qu 236.00
Median 476.00
Mean 11176.43
3rd Qu 1076.00
Max 200000.00

Registry Model

observational_model Study_Count
Cohort 17
Case-Control 2
Ecologic or Community 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 16
Cross-Sectional 2
Other 2
NA 1

Follow-up

target_duration Study_Count
1 Day 3
1 Year 3
10 Years 3
5 Years 2
6 Months 2
2 Weeks 1
20 Years 1
30 Years 1
4 Days 1
4 Weeks 1
48 Weeks 1
62 Months 1
64 Weeks 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03056924 Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab https://ClinicalTrials.gov/show/NCT03056924 Completed Boston Medical Center 2019-01-15
NCT03396458 Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg https://ClinicalTrials.gov/show/NCT03396458 Recruiting Hasselt University 2020-08-31
NCT01734018 An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01734018 Completed Hoffmann-La Roche 2012-08-31
NCT03825458 Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure. https://ClinicalTrials.gov/show/NCT03825458 Recruiting Hospices Civils de Lyon 2022-10-31
NCT03358108 A Prospective,Observational Follow-up Study of Nucleoside Treated Patients With Chronic Hepatitis B (OCEAN Study) https://ClinicalTrials.gov/show/NCT03358108 Recruiting Tongji Hospital 2020-12-01
NCT03329820 Quality of Life and Health Utility of Patients With CHB Infections https://ClinicalTrials.gov/show/NCT03329820 Completed The University of Hong Kong 2009-06-30
NCT03300414 Biologic Basis of Liver Cancer From Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT03300414 Completed University of California, Davis 2018-12-14
NCT03248622 Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection https://ClinicalTrials.gov/show/NCT03248622 Completed National Institutes of Health Clinical Center (CC) 2019-05-28
NCT03221049 Radiomics for Diagnosing Liver Diseases and Evaluating Progression https://ClinicalTrials.gov/show/NCT03221049 Recruiting Third Affiliated Hospital, Sun Yat-Sen University 2022-12-31
NCT03215732 Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal https://ClinicalTrials.gov/show/NCT03215732 Completed French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2019-07-31
NCT03181607 Efficacy and Adverse Effects of Nucleoside Analogues (TDF/LDT) in Preventing Mother-to-child Transmission of HBV https://ClinicalTrials.gov/show/NCT03181607 Enrolling by invitation The Third Affiliated Hospital of Guangzhou Medical University 2019-05-26
NCT03158818 Chronic Hepatitis B Virus Infection in Zambia https://ClinicalTrials.gov/show/NCT03158818 Recruiting University of Alabama at Birmingham 2021-01-31
NCT03149627 Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults https://ClinicalTrials.gov/show/NCT03149627 Completed University of Alabama at Birmingham 2018-12-19
NCT03097952 “Real-life” Cohort Study on Patients With Chronic HBV Infection in Jiangsu https://ClinicalTrials.gov/show/NCT03097952 Recruiting The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 2030-12-31
NCT03088995 Pilot Study of HIV and Hepatitis B and C Screening in Surgery https://ClinicalTrials.gov/show/NCT03088995 Completed Centre de Recherches et d’Etude sur la Pathologie Tropicale et le Sida 2017-09-01
NCT03042481 Off-therapy Response After Stopping Entecavir or Tenofovir https://ClinicalTrials.gov/show/NCT03042481 Recruiting Kaohsiung Medical University Chung-Ho Memorial Hospital 2019-05-31
NCT02995252 The HOPE Study: Characterizing Patients With Hepatitis B and C https://ClinicalTrials.gov/show/NCT02995252 Recruiting University of Maryland, Baltimore 2020-01-31
NCT02985450 A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada https://ClinicalTrials.gov/show/NCT02985450 Recruiting University of Calgary 2019-12-31
NCT02974829 REALM China Extension Study https://ClinicalTrials.gov/show/NCT02974829 Recruiting Nanfang Hospital of Southern Medical University 2022-01-31
NCT02909023 Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or Cured https://ClinicalTrials.gov/show/NCT02909023 Completed Hospices Civils de Lyon 2016-09-30
NCT02877589 Interest of Routine Screening for Hepatitis B and C in Patients Receiving Chemotherapy for Solid Tumors https://ClinicalTrials.gov/show/NCT02877589 Completed CHU de Reims 2013-07-31
NCT02876419 A Long Term Follow-up Study of Patients From the REP 301 Protocol https://ClinicalTrials.gov/show/NCT02876419 Active, not recruiting Replicor Inc. 2019-11-13
NCT02863757 Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02863757 Recruiting Humanity and Health Research Centre 2026-12-31
NCT02791386 Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy https://ClinicalTrials.gov/show/NCT02791386 Completed Bristol-Myers Squibb 2017-10-30
NCT02785835 Hepatocellular Carcinoma in HIV-infected Patients https://ClinicalTrials.gov/show/NCT02785835 Recruiting Hospital Universitario de Valme 2016-12-31
NCT02749864 Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP) https://ClinicalTrials.gov/show/NCT02749864 Completed Instituto de Investigación Marqués de Valdecilla 2017-04-01
NCT02719808 Study of Antiretroviral Therapy to Prevent HBV Intrauterine Infection https://ClinicalTrials.gov/show/NCT02719808 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2022-12-31
NCT02582333 Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue Therapy https://ClinicalTrials.gov/show/NCT02582333 Recruiting Taichung Veterans General Hospital 2020-10-31
NCT04356404 Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients https://ClinicalTrials.gov/show/NCT04356404 Recruiting Chinese University of Hong Kong 2022-05-31
NCT01350648 Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection https://ClinicalTrials.gov/show/NCT01350648 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01263600 Hepatitis B Research Network Pediatric Cohort Study (HBRN) https://ClinicalTrials.gov/show/NCT01263600 Active, not recruiting University of Pittsburgh 2020-09-30
NCT01263587 Hepatitis B Research Network Adult Cohort Study https://ClinicalTrials.gov/show/NCT01263587 Active, not recruiting University of Pittsburgh 2020-09-30
NCT00004850 Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT00004850 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT02566148 Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France https://ClinicalTrials.gov/show/NCT02566148 Completed French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2012-02-29
NCT02548325 Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study https://ClinicalTrials.gov/show/NCT02548325 Completed Corporacion Parc Tauli 2015-05-31
NCT02533544 Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT02533544 Completed The Catholic University of Korea 2018-10-31
NCT02511743 Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection https://ClinicalTrials.gov/show/NCT02511743 Completed Peking University First Hospital 2015-11-30
NCT02443233 Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong https://ClinicalTrials.gov/show/NCT02443233 Completed The University of Hong Kong 2016-12-31
NCT02387463 Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B Patients https://ClinicalTrials.gov/show/NCT02387463 Completed Beijing Ditan Hospital 2017-05-21
NCT02366286 Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants https://ClinicalTrials.gov/show/NCT02366286 Active, not recruiting Mayo Clinic 2022-12-31
NCT02344498 Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa https://ClinicalTrials.gov/show/NCT02344498 Active, not recruiting Oslo University Hospital 2020-12-31
NCT02336399 Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment https://ClinicalTrials.gov/show/NCT02336399 Active, not recruiting Beijing Ditan Hospital 2016-12-31
NCT02324218 This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age https://ClinicalTrials.gov/show/NCT02324218 Completed GlaxoSmithKline 2015-01-31
NCT02323308 Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination https://ClinicalTrials.gov/show/NCT02323308 Completed French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2014-06-30
NCT02313649 ShearWaveâ„¢ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B https://ClinicalTrials.gov/show/NCT02313649 Completed SuperSonic Imagine 2016-04-30
NCT02275221 Immune Response in Patients With Hepatitis B and C Infection https://ClinicalTrials.gov/show/NCT02275221 Recruiting Basildon and Thurrock University Hospitals NHS Foundation Trust 2019-12-31
NCT02267473 Hepatitis B Patients Under Oral Nucleos(t)Ide Treatment With Intermittent Assessment of Kidney Function https://ClinicalTrials.gov/show/NCT02267473 Active, not recruiting Johann Wolfgang Goethe University Hospital 2020-10-31
NCT02201407 An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B Study https://ClinicalTrials.gov/show/NCT02201407 Completed Hoffmann-La Roche 2017-04-10
NCT02167113 Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay https://ClinicalTrials.gov/show/NCT02167113 Completed Hologic, Inc. 2016-02-29
NCT02129829 PROLIFICA - West African Treatment Cohort for Hepatitis B https://ClinicalTrials.gov/show/NCT02129829 Active, not recruiting Imperial College London 2020-04-01
NCT02125071 Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation https://ClinicalTrials.gov/show/NCT02125071 Completed Seoul St. Mary’s Hospital 2015-08-31
NCT02112890 Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico https://ClinicalTrials.gov/show/NCT02112890 Completed GlaxoSmithKline 2016-05-02
NCT02108444 Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients https://ClinicalTrials.gov/show/NCT02108444 Completed Peking University 2013-12-31
NCT02075294 Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT02075294 Completed Beijing 302 Hospital 2012-10-31
NCT02069678 Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT02069678 Completed Chinese University of Hong Kong 2013-09-30
NCT01311947 Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01311947 Completed China Medical University Hospital 2012-03-31
NCT01311232 Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab https://ClinicalTrials.gov/show/NCT01311232 Completed Samsung Medical Center 2012-12-01
NCT01298037 HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01298037 Active, not recruiting University of Pennsylvania 2021-05-31
NCT01283074 An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas) https://ClinicalTrials.gov/show/NCT01283074 Completed Hoffmann-La Roche 2012-11-30
NCT01282762 Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney Disease https://ClinicalTrials.gov/show/NCT01282762 Completed Dynavax Technologies Corporation 2013-08-31
NCT02044523 Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound https://ClinicalTrials.gov/show/NCT02044523 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2018-06-30
NCT02044068 Hepatitis B Virus Vertical Transmission From HIV-HBV Co-infected Women https://ClinicalTrials.gov/show/NCT02044068 Completed Hopital Lariboisière 2015-09-30
NCT01988753 Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases https://ClinicalTrials.gov/show/NCT01988753 Completed Baylor College of Medicine 2016-06-30
NCT01970254 Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy https://ClinicalTrials.gov/show/NCT01970254 Active, not recruiting M.D. Anderson Cancer Center 2020-12-31
NCT01958229 Efficacy Study of Telbivudine in Chronic Hepatitis B Patients https://ClinicalTrials.gov/show/NCT01958229 Completed National Taiwan University Hospital 2012-03-31
NCT01957618 The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy https://ClinicalTrials.gov/show/NCT01957618 Enrolling by invitation National Taiwan University Hospital 2012-01-31
NCT01953458 Therapeutic Option for Hepatitis B and C: a French Cohort https://ClinicalTrials.gov/show/NCT01953458 Recruiting French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2022-08-31
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01924455 HBV-HIV Coinfection Research Network https://ClinicalTrials.gov/show/NCT01924455 Completed Virginia Commonwealth University 2019-03-31
NCT01863589 Drug Use Investigation for HEPSERA (Adefovir) Tablet https://ClinicalTrials.gov/show/NCT01863589 Completed GlaxoSmithKline 2007-06-30
NCT01855997 A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue https://ClinicalTrials.gov/show/NCT01855997 Completed Hoffmann-La Roche 2014-11-28
NCT01826760 Study of the Model to Predict 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver Failure https://ClinicalTrials.gov/show/NCT01826760 Completed Wenzhou Medical University 2010-05-31
NCT01810835 Prevention of Hepatitis B Virus Mother-to-child Transmission by Serovaccination. https://ClinicalTrials.gov/show/NCT01810835 Completed Hopital Lariboisière 2013-11-30
NCT01796457 HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01796457 Active, not recruiting University of Pennsylvania 2020-07-31
NCT01782794 Acceptability of Hepatitis B Vaccination in General Population https://ClinicalTrials.gov/show/NCT01782794 Completed GlaxoSmithKline 2012-06-30
NCT01777074 Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians https://ClinicalTrials.gov/show/NCT01777074 Completed GlaxoSmithKline 2012-04-30
NCT01772121 Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India https://ClinicalTrials.gov/show/NCT01772121 Completed Gilead Sciences 2012-10-31
NCT01732354 Study for Consolidation Period of Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01732354 Completed Tainan Municipal Hospital 2013-11-20
NCT01732081 “Real-life” Cohort of Patients With Chronic Hepatitis B Virus Infection https://ClinicalTrials.gov/show/NCT01732081 Recruiting University Hospital, Strasbourg, France 2021-01-31
NCT01730508 An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01730508 Completed Hoffmann-La Roche 2017-06-25
NCT03350074 HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue Therapy https://ClinicalTrials.gov/show/NCT03350074 Completed Central Hospital, Nancy, France 2016-05-01
NCT01705704 A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01705704 Completed Hoffmann-La Roche 2013-02-28
NCT01667432 An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01667432 Completed Hoffmann-La Roche 2014-08-12
NCT01645969 A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265 https://ClinicalTrials.gov/show/NCT01645969 Completed Hoffmann-La Roche 2012-10-31
NCT01623778 Optimization of Antiviral Therapy of Chronic HBV Infection https://ClinicalTrials.gov/show/NCT01623778 Completed Changhai Hospital 2011-12-31
NCT01574521 Seroepidemiologic Study of Spermatozoal Transmission of Hepatitis B Virus (HBV) https://ClinicalTrials.gov/show/NCT01574521 Completed Taizhou Hospital 2010-12-31
NCT01548820 Resistance to Lamivudine in HBV Egyptian Patients https://ClinicalTrials.gov/show/NCT01548820 Completed Ain Shams University 2012-11-30
NCT01531166 A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon https://ClinicalTrials.gov/show/NCT01531166 Completed Yonsei University 2014-08-31
NCT01502397 Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study https://ClinicalTrials.gov/show/NCT01502397 Completed The University of Hong Kong 2015-12-31
NCT01500265 Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus https://ClinicalTrials.gov/show/NCT01500265 Completed University Hospital, Limoges 2013-12-31
NCT01481649 Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) Exposure https://ClinicalTrials.gov/show/NCT01481649 Completed The University of Hong Kong 2015-02-28
NCT01401400 Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study https://ClinicalTrials.gov/show/NCT01401400 Completed Foundation for Liver Research 2015-06-30
NCT01376154 Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis) https://ClinicalTrials.gov/show/NCT01376154 Completed GlaxoSmithKline 2009-12-31
NCT01356901 Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients https://ClinicalTrials.gov/show/NCT01356901 Completed Bristol-Myers Squibb 2015-01-31
NCT01337479 A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials https://ClinicalTrials.gov/show/NCT01337479 Completed Bristol-Myers Squibb 2010-09-30
NCT01329419 HEPSERA Post Marketing Surveillance https://ClinicalTrials.gov/show/NCT01329419 Completed GlaxoSmithKline 2010-02-28
NCT01323452 Entecavir for Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01323452 Completed Foundation for Liver Research 2011-01-31
NCT04310787 Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure https://ClinicalTrials.gov/show/NCT04310787 Recruiting Third Affiliated Hospital, Sun Yat-Sen University 2020-08-15
NCT04264312 Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria https://ClinicalTrials.gov/show/NCT04264312 Completed Centers for Disease Control and Prevention, China 2019-09-28
NCT04237376 Chronic HBV Infection in Pregnant Women Taking TAF to Prevent Vertical Transmission https://ClinicalTrials.gov/show/NCT04237376 Recruiting New Discovery LLC 2020-09-30
NCT04211805 Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis B https://ClinicalTrials.gov/show/NCT04211805 Recruiting New Discovery LLC 2021-09-30
NCT04160897 Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT04160897 Enrolling by invitation Ruijin Hospital 2020-10-31
NCT04135235 Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis B https://ClinicalTrials.gov/show/NCT04135235 Recruiting Beijing Ditan Hospital 2021-08-01
NCT04038372 Hepatitis D Virus Infection Among Hepatitis B Virus Surface Antigen Positive Individuals https://ClinicalTrials.gov/show/NCT04038372 Completed Assiut University 2017-10-31
NCT04030039 Cohort Study of Clinical Outcomes in Chronic HBV Infection Patients With Low HBsAg Under Unplanned Intervention https://ClinicalTrials.gov/show/NCT04030039 Recruiting Beijing Ditan Hospital 2020-12-30
NCT04028856 Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT04028856 Completed Beijing Ditan Hospital 2019-06-30
NCT03977987 Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission https://ClinicalTrials.gov/show/NCT03977987 Completed Huashan Hospital 2018-12-30
NCT03977857 Computed Tomography Liver Volume for Predicting Short-term Mortality in Hepatitis B‐Acute‐on‐Chronic Liver Failure https://ClinicalTrials.gov/show/NCT03977857 Completed First Affiliated Hospital Xi’an Jiaotong University 2019-12-31
NCT03932851 Clinical Study on the Effect of IVF-ET on Mother-to-child Transmission of Hepatitis B Virus https://ClinicalTrials.gov/show/NCT03932851 Recruiting Beijing Ditan Hospital 2019-05-01
NCT03909191 Serum HBV RNA Value on Chronic Hepatitis B Virus Infection Manage https://ClinicalTrials.gov/show/NCT03909191 Active, not recruiting Changhai Hospital 2020-05-01
NCT03865966 Hepatitis B Virus Infection After Liver Transplantation in Children https://ClinicalTrials.gov/show/NCT03865966 Recruiting Children’s Hospital of Chongqing Medical University 2023-12-31
NCT03864263 Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents https://ClinicalTrials.gov/show/NCT03864263 Recruiting Children’s Hospital of Chongqing Medical University 2020-12-31
NCT03817697 Non-vaccination Factors Against Hepatitis B Virus in Drug Users https://ClinicalTrials.gov/show/NCT03817697 Completed Hospices Civils de Lyon 2019-09-04
NCT03777969 Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients https://ClinicalTrials.gov/show/NCT03777969 Recruiting Beijing Friendship Hospital 2020-12-31
NCT03752658 TAF Real World Study for Universal Effectiveness https://ClinicalTrials.gov/show/NCT03752658 Recruiting Tongji Hospital 2023-05-01
NCT03740789 Evaluation of Antiviral Indications on Chronic HBV Infection With Different Transaminase Levels https://ClinicalTrials.gov/show/NCT03740789 Active, not recruiting First Affiliated Hospital Xi’an Jiaotong University 2019-04-30
NCT03702998 Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population https://ClinicalTrials.gov/show/NCT03702998 Recruiting Chinese University of Hong Kong 2020-07-31
NCT03692897 An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection https://ClinicalTrials.gov/show/NCT03692897 Active, not recruiting Target PharmaSolutions, Inc. 2023-01-31
NCT03643172 Terminator 2 Register https://ClinicalTrials.gov/show/NCT03643172 Recruiting Hannover Medical School 2020-07-31
NCT03642340 A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo https://ClinicalTrials.gov/show/NCT03642340 Recruiting IlDong Pharmaceutical Co Ltd 2023-05-14
NCT03640728 The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure https://ClinicalTrials.gov/show/NCT03640728 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2021-04-30
NCT03625258 Mutations of the Pre-core Region of Hepatite B Virus (HBV) https://ClinicalTrials.gov/show/NCT03625258 Completed Centre Hospitalier Universitaire, Amiens 2017-02-01
NCT03587467 Study on Gut Microbiota in Chronic HBV Infected Patients https://ClinicalTrials.gov/show/NCT03587467 Recruiting Zhongshan Hospital Xiamen University 2020-12-01
NCT03579576 Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar https://ClinicalTrials.gov/show/NCT03579576 Completed Right to Care 2019-03-30
NCT03559790 Treatment Efficacy and Safety of TDF-TAF Switch Study in South Korea https://ClinicalTrials.gov/show/NCT03559790 Recruiting The Catholic University of Korea 2020-08-31
NCT03529760 Chemotherapy Efficacy and Follow-up Study of Hepatitis B Virus Infection and Reactivation in Children With Leukemia https://ClinicalTrials.gov/show/NCT03529760 Recruiting Children’s Hospital of Chongqing Medical University 2019-07-15
NCT03511794 Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant https://ClinicalTrials.gov/show/NCT03511794 Enrolling by invitation National Institutes of Health Clinical Center (CC) 2021-06-01
NCT03459768 Cohort Study on People Who Inject Drugs in Senegal https://ClinicalTrials.gov/show/NCT03459768 Active, not recruiting French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2020-02-29
NCT03426618 A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT03426618 Completed Bristol-Myers Squibb 2019-03-13
NCT03425513 Hepatitis B Virus Prevalence and Risk Factors in Belgium https://ClinicalTrials.gov/show/NCT03425513 Completed Hasselt University 2017-11-27
NCT01267162 Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients https://ClinicalTrials.gov/show/NCT01267162 Completed Medical Procare PLLC 2013-11-30
NCT01264107 An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine https://ClinicalTrials.gov/show/NCT01264107 Completed Bukwang Pharmaceutical 2012-01-31
NCT01163240 Epidemiological Study in Children and Adolescents With Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01163240 Completed Novartis 2011-09-30
NCT01155427 Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB) https://ClinicalTrials.gov/show/NCT01155427 Completed Bristol-Myers Squibb 2010-04-30
NCT01128686 Lamivudine(LAM) Good Responder Study https://ClinicalTrials.gov/show/NCT01128686 Completed ViiV Healthcare 2011-06-30
NCT01107483 Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) Infection https://ClinicalTrials.gov/show/NCT01107483 Completed Sun Yat-sen University 2010-02-28
NCT01105559 Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine https://ClinicalTrials.gov/show/NCT01105559 Completed Sanofi 2011-11-30
NCT01090531 Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral Therapy https://ClinicalTrials.gov/show/NCT01090531 Active, not recruiting Johann Wolfgang Goethe University Hospital 2021-08-31
NCT01011738 An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys https://ClinicalTrials.gov/show/NCT01011738 Completed Hoffmann-La Roche 2014-11-18
NCT00970216 Study of Telbivudine in Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT00970216 Completed Chang Gung Memorial Hospital 2016-01-31
NCT00956891 Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation https://ClinicalTrials.gov/show/NCT00956891 Completed Sun Yat-sen University 2009-06-30
NCT00946010 Investigation of Hepatitis B and Hepatitis C in Taiwan https://ClinicalTrials.gov/show/NCT00946010 Completed National Taiwan University Hospital 2010-08-31
NCT00881036 Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients https://ClinicalTrials.gov/show/NCT00881036 Completed Kyoto University 2015-07-31
NCT00876148 Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting https://ClinicalTrials.gov/show/NCT00876148 Completed Azienda Ospedaliera San Giovanni Battista NA
NCT00873652 Observational Study of Immune Response to Hepatitis B Childhood Booster https://ClinicalTrials.gov/show/NCT00873652 Completed University of Oxford 2011-01-31
NCT02019966 A Korean Cohort Study of TDF Rescue Therapy for Difficult-to-treat CHB Patients: a Comparison Between TDF Monotherapy and TDF-based Combination Therapy https://ClinicalTrials.gov/show/NCT02019966 Completed Yonsei University 2017-08-04
NCT01581554 Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01581554 Completed National Institutes of Health Clinical Center (CC) NA
NCT03345498 Entecavir for Decompensated HBV Cirrhosis https://ClinicalTrials.gov/show/NCT03345498 Completed Sanjay Gandhi Postgraduate Institute of Medical Sciences 2018-06-30
NCT02005146 Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs https://ClinicalTrials.gov/show/NCT02005146 Completed Andalusian Network for Design and Translation of Advanced Therapies 2014-12-31
NCT01182311 Duration of Long-term Immunity After Hepatitis B Virus Immunization https://ClinicalTrials.gov/show/NCT01182311 Completed National Institutes of Health Clinical Center (CC) NA
NCT03528941 The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib https://ClinicalTrials.gov/show/NCT03528941 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2020-08-31
NCT03155984 Optimizing HBV Management During Anti-CD20 Antibodies https://ClinicalTrials.gov/show/NCT03155984 Completed The University of Hong Kong 2017-06-01
NCT02060162 Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa https://ClinicalTrials.gov/show/NCT02060162 Active, not recruiting University of Alabama at Birmingham 2021-06-30
NCT03181113 Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa Therapy https://ClinicalTrials.gov/show/NCT03181113 Enrolling by invitation Xiamen Amoytop Biotech Co., Ltd. 2020-12-31
NCT04032275 Correlation Between Virus and Biochemical Characteristics and Liver Histological Damage in Untreated Chronic HBV Infection https://ClinicalTrials.gov/show/NCT04032275 Completed Beijing Ditan Hospital 2018-12-30
NCT00782158 Hepatitis B and HIV Co-Infection in Patients in Uganda https://ClinicalTrials.gov/show/NCT00782158 Completed National Institutes of Health Clinical Center (CC) NA
NCT00769730 Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication https://ClinicalTrials.gov/show/NCT00769730 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2009-02-28
NCT00645736 CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study https://ClinicalTrials.gov/show/NCT00645736 Completed Gilead Sciences 2008-10-31
NCT00512941 Laboratory Profile of Hepatitis B and C in Users of a Reference Service https://ClinicalTrials.gov/show/NCT00512941 Completed UPECLIN HC FM Botucatu Unesp NA
NCT00476723 HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection https://ClinicalTrials.gov/show/NCT00476723 Completed The HIV Netherlands Australia Thailand Research Collaboration 2007-12-31
NCT00404989 Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women. https://ClinicalTrials.gov/show/NCT00404989 Recruiting Syneos Health 2099-01-31
NCT00388674 Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection https://ClinicalTrials.gov/show/NCT00388674 Completed Bristol-Myers Squibb 2016-10-26
NCT00381992 Risk Assessment of Long-Haul Truck Drivers https://ClinicalTrials.gov/show/NCT00381992 Completed Wake Forest University Health Sciences 2010-03-31
NCT00362674 Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial https://ClinicalTrials.gov/show/NCT00362674 Completed Bukwang Pharmaceutical NA
NCT00912847 Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00912847 Completed Chinese University of Hong Kong 2004-04-30
NCT00361179 Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C https://ClinicalTrials.gov/show/NCT00361179 Completed National Taiwan University Hospital NA
NCT00342186 Genes Involved in Resistance or Susceptibility to Hepatitis B Virus https://ClinicalTrials.gov/show/NCT00342186 Completed National Institutes of Health Clinical Center (CC) 2018-02-22
NCT00263614 Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases. https://ClinicalTrials.gov/show/NCT00263614 Completed Gilead Sciences NA
NCT00199732 Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a https://ClinicalTrials.gov/show/NCT00199732 Completed University Hospital, Limoges 2009-07-31
NCT00168194 Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History https://ClinicalTrials.gov/show/NCT00168194 Completed The Alfred NA
NCT00161941 Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216 https://ClinicalTrials.gov/show/NCT00161941 Completed Pfizer NA
NCT00158717 Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV. https://ClinicalTrials.gov/show/NCT00158717 Completed Gilead Sciences 2006-04-30
NCT00155155 Studies of Immune Responses in Patients With Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT00155155 Completed National Taiwan University Hospital 2008-04-30
NCT00146835 Post-marketing Safety Study of GSK Biological’s Pediarixâ„¢ Vaccine https://ClinicalTrials.gov/show/NCT00146835 Completed GlaxoSmithKline 2006-06-30
NCT00146705 Long Term Follow-up of Pegylated-Interferon Alpha-2b https://ClinicalTrials.gov/show/NCT00146705 Completed Foundation for Liver Research NA
NCT00142740 Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025 https://ClinicalTrials.gov/show/NCT00142740 Completed University of North Carolina, Chapel Hill 2008-06-30
NCT00141999 Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents https://ClinicalTrials.gov/show/NCT00141999 Completed Centers for Disease Control and Prevention 2005-03-31
NCT00138268 Pilot Study Freeze and Transport Immune Cells https://ClinicalTrials.gov/show/NCT00138268 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00097006 Retrovirus Epidemiology Donor Study-II (REDS-II) https://ClinicalTrials.gov/show/NCT00097006 Completed National Heart, Lung, and Blood Institute (NHLBI) 2009-09-30
NCT00059267 Prevention of Recurrent Hepatitis B After Liver Transplantation https://ClinicalTrials.gov/show/NCT00059267 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2007-11-30
NCT00001712 Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan https://ClinicalTrials.gov/show/NCT00001712 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03108794 A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B https://ClinicalTrials.gov/show/NCT03108794 Recruiting Beijing Friendship Hospital 2022-12-31
NCT03025074 Blood Collection Biorepository for Liver Disease Research https://ClinicalTrials.gov/show/NCT03025074 Recruiting State University of New York at Buffalo 2099-12-31
NCT02699736 EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV https://ClinicalTrials.gov/show/NCT02699736 Enrolling by invitation Rigshospitalet, Denmark 2030-12-31
NCT02596438 Thousand Asian American Study https://ClinicalTrials.gov/show/NCT02596438 Completed University of California, Davis 2017-09-30
NCT02038088 The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus Replication https://ClinicalTrials.gov/show/NCT02038088 Completed Southwest Hospital, China 2014-08-31
NCT02766933 Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study https://ClinicalTrials.gov/show/NCT02766933 Active, not recruiting Mayo Clinic 2022-05-31
NCT02263755 Establishment of Retrospective and Prospective Multicenter Cohort for Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT02263755 Completed Yonsei University 2015-06-25
NCT02031913 Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD https://ClinicalTrials.gov/show/NCT02031913 Recruiting Seoul National University Boramae Hospital 2022-11-30
NCT02025842 Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02025842 Completed Azienda Ospedaliera San Camillo Forlanini 2013-12-31
NCT01962155 Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters https://ClinicalTrials.gov/show/NCT01962155 Completed Peking University First Hospital 2015-12-31
NCT01908660 Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions https://ClinicalTrials.gov/show/NCT01908660 Completed Valme University Hospital 2015-09-30
NCT01679769 Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01679769 Completed Peking University First Hospital 2015-10-31
NCT01590615 Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy https://ClinicalTrials.gov/show/NCT01590615 Completed Gilead Sciences 2017-04-04
NCT04139850 The Establishment of Korean Hepatitis B Patients Cohort https://ClinicalTrials.gov/show/NCT04139850 Recruiting Yonsei University 2026-08-31
NCT04065230 Study of Tenofovir Alafenamide Fumarate Tablets (TAF) in Blocking Mother-to-child Transmission of Hepatitis B Virus https://ClinicalTrials.gov/show/NCT04065230 Recruiting Southeast University, China 2021-08-31
NCT04062253 Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid https://ClinicalTrials.gov/show/NCT04062253 Recruiting Hospital Universitario Infanta Leonor 2020-02-15
NCT03734783 IL-35+Breg/Il-35 Effect on T Cell Immune in Patients With CHB https://ClinicalTrials.gov/show/NCT03734783 Completed Changhai Hospital 2019-11-15
NCT03680183 Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV) https://ClinicalTrials.gov/show/NCT03680183 Recruiting Affiliated Cancer Hospital & Institute of Guangzhou Medical University 2019-03-01
NCT03597633 Tenofovir Combination or Mono-therapy for MDR CHB https://ClinicalTrials.gov/show/NCT03597633 Active, not recruiting Korea University 2018-12-31
NCT03535779 Characterisation of Human B Cell Maturation in Response to Vaccination https://ClinicalTrials.gov/show/NCT03535779 Completed Imperial College London 2017-06-15
NCT03425994 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfection https://ClinicalTrials.gov/show/NCT03425994 Active, not recruiting National Taiwan University Hospital 2019-02-22